Carna Biosciences Inc Sustainability Reports

Carna Biosciences, Inc. discovers and develops small-molecule drug therapies targeting kinases to treat unmet medical needs in oncology and autoimmune diseases. It also provides comprehensive kinase drug discovery support tools, reagents, and profiling services to global pharmaceutical companies.

Sector: Manufacturing

Country: Japan

Exchange: Tokyo Stock Exchange

FIGI: BBG001SQWQC3

No reports are currently available in our catalogue.